PDLIM7 and cancer: LMP1 activates several signaling pathways known in cancer progression, including the NF-κB [11,12], mitogen-activated protein kinase (MAPK) [13], c-Jun N-terminal kinase (JNK) [14], and phosphatidylinositol 3-kinase (PI3K)-Akt pathways [15].